ArticleMolecular therapy. Advances2026
Integrating multiplex digital PCR and long-read sequencing toward standardized genome integrity and purity characterization of rAAV9.
Article in Molecular therapy. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recombinant adeno-associated virus (rAAV) production can yield heterogeneous viral particle populations containing incomplete genomes and co-packaged DNA impurities that may compromise dosing accuracy and safety. Here, we applied long-read next-generation sequencing (NGS) to characterize the genome and DNA impurity profiles of rAAV9 and compare genome integrity estimates with digital PCR (dPCR). A 4-plex dPCR assay targeting four regions of the rAAV9 genome was developed to enable simultaneous assessment of genome titer and integrity in both intact rAAV9 particles and extracted genomes. To prepare samples for both dPCR and long-read NGS, rAAV9 genomes were released using a heat-based protocol or a commercial extraction kit and sequenced. Long-read NGS revealed the presence of host cell DNA, plasmid DNA, and chimeric reads. The chimeric reads spanned from the inverted terminal repeats sequences into the transfer plasmid backbone, potentially due to mispackaging events. Genome integrity estimates differed significantly between methods, with dPCR reporting higher genome integrity than long-read NGS. Together, multiplex dPCR and long-read NGS provide complementary information on rAAV critical quality attributes and support more comprehensive quality control of rAAV batches across process development and batch release.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.